NAYA (NAYA Biosciences Corp) שווי פירמה כולל

NAYA Biosciences is actively developing innovative NK-therapy to combat solid tumors. This chart reflects a current share price of . The company's strategy relies on long-term intellectual property protection, establishing a foundation for future market dominance. Additionally, the business is based on partnerships with universities, leveraging laboratory resources to refine immune treatment methods.

NAYA Biosciences' successes in developing anti-cancer therapies are directly reflected in the enterprise value dynamics, linking market valuation to financial stability. The sum of market capitalization and debt minus liquid assets determines the actual buyout cost of the business, which is critical for a biotech firm whose viability depends on external financing and partnerships with oncology centers in the absence of stable revenue.